A bispecific antibody targeting CLDN18.2 and 4-1BB induces potent anti-tumor efficacy with an extraordinary safety profile Junying Chen,Weifeng Huang, Zhiquan Liang,Xiaoniu Miao,Shaogang Peng,Chao Wang, Tiantian Dong,Andy Tsun,Yi LuoCANCER RESEARCH（2022）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
